What We Do

Representative Hatch -Waxman Litigations

  • Kowa Co. Ltd. v. Sawai USA, et al., 14-cv-05575 (SD NY 2014)(pitavastatin calcium, Livalo®)
  • The Medicines Company v. Accord Healthcare, Inc., 14-cv-00626 (NC 2014)(bivalirudin, Angiomax®)
  • Eli Lilly & Co et al. v. Accord Healthcare, Inc, USA et al., 1:14-cv-389 (S.D. Ind. 2014)(prasugrel, Effient®)
  • Pfizer v. Amneal Pharmaceuticals, LLC., 1.13-cv-00157-GMS (D. Del. 2013)(fesoterodine, Toviaz®) 
  • Novartis v. Accord Healthcare, Inc,. 1:13-cv-01013-EGS (D. D.C. 2013) 
  • Novartis v. Accord Healthcare, Inc.,2:13-cv-07178-SDW-MCA (D. N.J. 2013) (zoledronic acid; Zometa®) 
  • Cephalon v. Accord Healthcare, Inc., 1:13-02095-UNA (D. Del. 2013)(bundamustin) 
  • Pfizer v. Accord Healthcare, Inc., 1.13-cv-1110-GMS (D. Del. 2013) (fesoterodine; Toviaz®) 
  • Eli Lilly v. Accord Healthcare, Inc., 1:12-cv-00086-TWP-DKL (S.D. Ind. 2012) (pemetrexed; Alimta®) 
  • Merck Sharp & Dohme Corp. v. Accord Healthcare, Inc. USA, et al., 3:12-cv-03324-PGS-LHG (D. N.J. 2012)(fosaprepitant; Emend IV ®) 
  • Aventis Pharma S.A. et al. v. Accord Healthcare Inc. USA, 1:11-cv-00018-GMS (D. Del. 2011)(docetaxel--check) 
  • AstraZeneca AB et al. v. Hanmi USA Inc., 3:11-CV-00760-JAP-TJB (D. NJ. 2011) (esomeprazole; Nexium®) 
  • Hoffman-La Roche Inc. v. Accord Healthcare, Inc., 2:11-cv-01192-ES-CLW (D. N.J. 2011)(capecitabine) 
  • Hoffman-La Roche Inc. v. Accord Healthcare, Inc., 2:11-cv-03663-ES-CLW (D. N.J. 2011) 
  • Pfizer Inc. et al., v. Intas Pharmaceuticals Ltd. et al., 1:11-cv-01253 (D. Del. 2011)(temsirolimus; Torisel ®) 
  • Pfizer Inc. et al. v. Alembic Ltd. et al., 1:11-cv-01213-GMS (D. Del. 2011)(pregabalin; Lyrica®) 
  • Novartis AG et al v. Accord healthcare, Inc. USA et al., 1:11-cv-01631-EGS (D. D.C. 2011) 
  • Novartis Pharmaceuticals Corp., v. Macleods Pharmaceuticals Ltd., 1:10-cv-00532-JEB (D. D.C. 2010) 
  • Pfizer, Inc., et al. v. Wockhardt Limited et al., 1:09-cv-00307-GMS (D. Del. 2009) (pregabalin; Lyrica®) 
  • Eli Lilly and Company v. Wockhardt Limited et al., No. 1:08-cv-01547-TWP-TAB (S.D. In. 2008)(duloxetine; Cymbalta®) 
  • In Re Alfuzosin Hydrochloride, MDL Docket No. 08-md-1941-GMS (D. Del. 2008) 
  • Sanofi-Aventis et al v. Wockhardt Limited et al, 1:08-cv-00150-GMS (D. Del. 2008) 
  • Forest Labs., et al. vs. Wockhardt USA LLC et al., 1:08-cv-00021-LPS (D. Del. 2008)(memantine; Namenda® 
  • Merck & Co., v. Ranbaxy, Inc., 1:07-cv-00229-GMS (D. Del. 2007)(imipenem/cilastatin; Primaxin IV ®) 
  • Ortho McNeil Pharmaceutical, Inc. and Daiichi Pharmaceutical Co., Ltd. v. Lupin Ltd., et al., 3:06-cv-04999-GEB-TJB (D. N.J. 2006) (levofloxacin; Levaquin®) 
  • Ortho McNeil Pharmaceutical, Inc. and Daiichi Pharmaceutical Co., Ltd. v. Ben Venue Laboratories, Inc. et al., 3:03-cv-01269 (D. N.J. 2003) (levofloxacin; Levaquin®) 
  • Ortho-McNeil Pharm., Inc. and Daiichi Pharmaceutical Co. Ltd. v. Mylan Labs., Inc., 1:02-cv-00032-IMK-JSK (N.D. W. Va. 2002) (levofloxacin; Levaquin®) 
  • Ortho McNeil Pharmaceutical, Inc. and Daiichi Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, et al. 3:02-cv-02794-GEB-JJH (D. N.J. 2002) (levofloxacin; Levaquin®)